French Senat
Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the conduct of clinical trials with and supply of medicinal products for human use containing or consisting of genetically modified organisms intended to treat or prevent coronavirus disease
Scrutiny details
Scrutiny date: 30/06/2020
Subsidiarity Concern:
No Important information to exchange
No Veto
Information on parliamentary scrutiny
On 30 June, the Working Group on subsidiarity of the European Affairs Committee decided not to intervene further under the subsidiarity principle.
| Linked files | Links |